The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA)-Reference-Cited by-同舟云学术

The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA)

Published:1995-10 Issue:2-3 Volume:30 Page:161-169
ISSN:1011-1344
Container-title:Journal of Photochemistry and Photobiology B: Biology
language:en
Short-container-title:Journal of Photochemistry and Photobiology B: Biology

Author:

Aveline Béatrice M.,Hasan Tayyaba,Redmond Robert W.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biophysics,Radiological and Ultrasound Technology,Radiation

Reference35 articles.

1. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives;Richter;Photochem. Photobiol.,1990

2. Photosensitizing potency of structural analogues of benzoporphyrin derivative (BPD) in mouse tumor model;Richter;Br. J. Cancer,1991

3. Preferential uptake of benzoporphyrin derivative by leukemic versus normal tumor cells;Jamieson;Leuk. Res.,1990

4. Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood;Neyndorff;Transfusion,1990

5. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA);Aveline;Photochem. Photobiol.,1994

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transmission Electron Microscopy Study of a Nanosuspension of Verteporfin and Evaluation of Stability in Human Serum;Microscopy and Microanalysis;2024-07

2. A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin–Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes;ACS Applied Bio Materials;2024-06-27

3. Methods for assessing and removing non‐specific photoimmunotherapy damage in patient‐derived tumor cell culture models;Photochemistry and Photobiology;2024-05-10

4. Porphysome Engineered With Specific Protein Binding Sites as a Multimodal Theranostic Nanocarrier for Targeted Protein Delivery;Chemistry & Biodiversity;2024-05-03

5. Carrier‐Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery;Advanced Science;2024-03-06